Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has completed the spin-out of Onset Therapeutics, LLC, its wholly owned subsidiary focused on the Dermatology market. Onset will become part of PreCision Dermatology, Inc., a newly founded company that...
HealthLeaders-InterStudy and Fingertip Formulary find that pharmacy directors expect health plans to cover Collegium's COL-003 and King Pharmaceutical's Remoxy over other emerging agents for chronic pain. According to the new report entitled Formulary Advantages in Analgesics for Chronic Pain...